Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence W Hallahan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|July 16, 2019
Incorporating the probability of competing event(s) into the preeclampsia competing risk algorithmDavid A Krantz, Terrence W Hallahan
Obstetrics and Gynecology|August 9, 2003
Incorporation of inhibin-A in second-trimester screening for Down syndromeTerrence W Hallahan, David A Krantz, James N Macri
Clinics in Laboratory Medicine|July 20, 2010
Screening for open neural tube defectsDavid A Krantz, Terrence W Hallahan, John E Sherwin
Clinics in Laboratory Medicine|May 29, 2016
Screening for Open Neural Tube DefectsDavid A Krantz, Terrence W Hallahan, Jonathan B Carmichael
Clinical Chemistry|January 5, 2006
First-trimester Down syndrome screeningTerrence W Hallahan, David A Krantz, V James Macri, et al.
Prenatal Diagnosis|July 29, 2005
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening programDavid A Krantz, Terrence W Hallahan, V James Macri, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocolMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Obstetrics and Gynecology|September 23, 2010
Undermeasurement of nuchal translucencies: implications for screeningMark I Evans, David A Krantz, Terrence W Hallahan, et al.
American Journal of Obstetrics and Gynecology|November 16, 2011
First-trimester screening in tripletsDavid A Krantz, Terrence W Hallahan, Kuanglin He, et al.
American Journal of Obstetrics and Gynecology|March 14, 2003
Combined first-trimester versus second-trimester serum screening for Down syndrome: a cost analysisWilliam Cusick, Philip Buchanan, Terrence W Hallahan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|July 16, 2019
Incorporating the probability of competing event(s) into the preeclampsia competing risk algorithmDavid A Krantz, Terrence W Hallahan
Obstetrics and Gynecology|August 9, 2003
Incorporation of inhibin-A in second-trimester screening for Down syndromeTerrence W Hallahan, David A Krantz, James N Macri
Clinics in Laboratory Medicine|July 20, 2010
Screening for open neural tube defectsDavid A Krantz, Terrence W Hallahan, John E Sherwin
Clinics in Laboratory Medicine|May 29, 2016
Screening for Open Neural Tube DefectsDavid A Krantz, Terrence W Hallahan, Jonathan B Carmichael
Clinical Chemistry|January 5, 2006
First-trimester Down syndrome screeningTerrence W Hallahan, David A Krantz, V James Macri, et al.
Prenatal Diagnosis|July 29, 2005
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening programDavid A Krantz, Terrence W Hallahan, V James Macri, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocolMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Obstetrics and Gynecology|September 23, 2010
Undermeasurement of nuchal translucencies: implications for screeningMark I Evans, David A Krantz, Terrence W Hallahan, et al.
American Journal of Obstetrics and Gynecology|November 16, 2011
First-trimester screening in tripletsDavid A Krantz, Terrence W Hallahan, Kuanglin He, et al.
American Journal of Obstetrics and Gynecology|March 14, 2003
Combined first-trimester versus second-trimester serum screening for Down syndrome: a cost analysisWilliam Cusick, Philip Buchanan, Terrence W Hallahan, et al.
Pageof 2